Leadiant fails to end Spanish probe into dominance abuse with commitments
MLex Summary: Drgumaker Leadiant Biosciences saw the Spanish competition authority reject commitments to end an antitrust probe over its alleged abuse of dominance in the production and supply of its orphan...To view the full article, register now.
Already a subscriber? Click here to view full article